Efficacy and safety of a patch vaccine containing heat-labile toxin from Escherichia coli against travellers' diarrhoea: a phase 3, randomised, double-blind, placebo-controlled field trial in travellers from Europe to Mexico and Guatemala

Enterotoxigenic Escherichia coli (ETEC) is a major cause of travellers' diarrhoea. We investigated the efficacy and safety of a skin-patch vaccine containing the pathogen's heat-labile toxin (LT) in a population of travellers to Mexico and Guatemala. In this phase 3, randomised, double-bli...

Full description

Saved in:
Bibliographic Details
Published inThe Lancet infectious diseases Vol. 14; no. 3; pp. 197 - 204
Main Authors Behrens, Ronald H, Cramer, Jakob P, Jelinek, Tomas, Shaw, Hilary, von Sonnenburg, Frank, Wilbraham, Darren, Weinke, Thomas, Bell, David J, Asturias, Edwin, Pauwells, Hermann L Enkerlin, Maxwell, Roberto, Paredes-Paredes, Mercedes, Glenn, Gregory M, Dewasthaly, Shailesh, Stablein, Donald M, Jiang, Zhi-Dong, DuPont, Herbert L
Format Journal Article
LanguageEnglish
Published London Elsevier Ltd 01.03.2014
Lancet Publishing Group
Elsevier Limited
Subjects
Online AccessGet full text

Cover

Loading…